MedPath

Intermittent CPAP in hypoxemic COVID patients

Not Applicable
Recruiting
Conditions
COVID-19 Infection.
Pneumonia due to SARS-associated coronavirus
J12.81
Registration Number
IRCT20200723048178N2
Lead Sponsor
Pakistan Institute of Medical Sciences, Islamabad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
93
Inclusion Criteria

Hospitalized patients with severe COVID-19 infection
Patients requiring supplemental oxygen of 10 litres or more

Exclusion Criteria

Unco-operative patient
Patients with Pneumothorax
Patients with Surgical emphysema
GCS less than 13
Excessive respiratory secretions
Shock

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In-hospital mortality. Timepoint: 28 days after intervention. Method of measurement: A Questionnaire will be used to record the data.
Secondary Outcome Measures
NameTimeMethod
The duration of hospital stay. Timepoint: 28 days following the intervention. Method of measurement: A Questionnaire will be used to record the data.;The use of non-invasive or invasive mechanical ventilation. Timepoint: 28 days after intervention. Method of measurement: A Questionnaire will be used to record the data.
© Copyright 2025. All Rights Reserved by MedPath